Natixis »

Compass Therapeutics shares owned by Natixis

Quarter-by-quarter ownership of Compass Therapeutics (CMPX) shares owned by Natixis from 13F filings

Historical chart of Natixis investment in Compass Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Compass Therapeutics held by Natixis consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Compass Therapeutics by Natixis

Quarter filed Position value Share count Share price at filing
2026-06-30 $652k 298k 2.19

More positions owned by Natixis

Vanguard Index Fds S&p 500 Etf Shs (VOO)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Apple (AAPL)
Micron Technology (MU)
Microsoft Corporation (MSFT)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Tesla Motors (TSLA)
Spdr Series Trust St Str P500etf (SPYM)
Energy Transfer Com Ut Ltd Ptn (ET)
Broadcom (AVGO)
Oracle Corporation (ORCL)
JPMorgan Chase & Co. (JPM)

View all positions for Natixis

Top funds holding Compass Therapeutics

Tang Capital Management
OrbiMed Advisors
Suvretta Capital Management
BlackRock
Enavate Sciences GP
Vivo Capital
State Street Corporation
Vanguard Capital Management
Palo Alto Investors
Millennium Management
Geode Capital Management
Vanguard Portfolio Management
Citadel Advisors
Qube Research & Technologies
Blue Owl Capital Holdings

View all funds holding Compass Therapeutics